US biotech Arvinas has promoted Ian Taylor to president of R&D. Angela Cacace will take over from Dr Taylor in his current role of chief scientific officer. 18 June 2024

Biotechnology

Enterprise Therapeutics appoints Dr Renu Gupta as CMO

Enterprise Therapeutics, appoints Dr Renu Gupta as CMO 17 June 2024

Biotechnology

Connect Biopharma strengthens leadership team

Connect Biopharma strengthens leadership team 13 June 2024

Biotechnology

Bhaskar Strivstava joins Triveni Bio as CMO

Bhaskar Strivstava joins Triveni Bio as CMO 12 June 2024

Biotechnology

Change at the top for Regenxbio

US gene therapy company Regenxbio has announced that co-founder Kenneth Mills is to step down as president and chief executive following 15 years of leadership 12 June 2024

Pharmaceutical

Senior biotech head announces departure from Bayer

In a post on LinkedIn, Bayer (BAYN: DE) senior VP and biotech head Jens Vogel has announced his intention to step down. 12 June 2024

Biotechnology

Doug Williamson among three senior appointments at QurAlis

Days after announcing a deal with US pharma major Eli Lilly, biotech start-up QurAlis has made another announcement. 11 June 2024

Biotechnology

Thermosome names Sabine Hauck as chief technical officer

Thermosome names Sabine Hauck as chief technical officer 11 June 2024

Biotechnology

Macomics names chief business officer

Macomics names chief business officer 10 June 2024

Pharmaceutical

Michaela Eikermann returns to Germany’s IQWiG as deputy director

Michaela Eikermann returns to Germany’s IQWiG as deputy director 10 June 2024

Biotechnology

New chief medical officer for USA-focused I-Mab

I-Mab has appointed Phillip Dennis as chief medical officer, overseeing the company's global clinical development efforts and joining the executive leadership t 7 June 2024

Biotechnology

Exscientia appoints new leaders to strengthen oncology expertise

Exscientia appoints new leaders to strengthen oncology expertise 6 June 2024

Pharmaceutical

Amarin appoints new CEO

Amarin appoints new CEO 5 June 2024

Pharmaceutical

New chief commercial officer to help UroGen keep growing

Bladder cancer specialist UroGen Pharma has appointed David Lin as chief commercial officer. 4 June 2024

Pharmaceutical

Investors hope shake-up at Ikena could turn things around

Ikena Oncology has announced the discontinuation of its IK-930 program, as well as plans to slash its workforce by about 50%. 29 May 2024